Changes in Sense of Taste of Patients Submitted to Hematopoietic Stem Cell Transplantation
NCT03498950 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2021-05-12
Summary
During conditioning with chemotherapy and radiotherapy for the transplantation of hematopoietic stem cells (HSCT), oral changes, such as mucositis, xerostomia infections and dysgeusia may occur. Low level laser therapy is used to minimize the intensity of the lesions, prevent ulcerations in the mucosa, and diminish the time of healing. To verify the efficacy of low level laser therapy in the prevention of dysgeusia in patients undergoing allogenic HSCT and detect the frequency of dysgeusia, the flavors most changed, and the association of these changes with the clinical conditions of the patient. The study sample will be composed of 80 patients selected at the Hematopoietic Stem Cell Transplantation Center of the "Hospital Israelita Albert Einstein". The patients will be randomized and distributed into two groups: Placebo Group (n=40) - submitted to the routine laser therapy protocol in addition to simulated laser irradiation on the taste papillae; Test Group (n= 40) - submitted to the same laser therapy protocol as that of the Placebo Group, however, laser irradiation on the taste papillae will be effective. Daily intraoral exam will be performed in all the patients to evaluate mucositis, xerostomia and depapillation. The taste acuity test will determine the function of taste, using samples with the four basic flavors. This will be performed on the first day of conditioning (T0), during the stage of neutropenia (T1), at the time of discharge after transplantation (T2) and 100 days after transplantation (T3). A questionnaire will also be applied to evaluate the impact of changes in taste, smell and xerostomia on the quality of life. Our hypothesis is that the laser irradiation on the lingual papillae would help to prevent the changes in the cells of the taste papillae, preserving their morphology and function, which may attenuate the change in sense of taste and have a positive impact on the quality of life of patients during transplantation.
Conditions
- Taste Disorders
Interventions
- OTHER
-
laser therapy
laser irradiation on the taste papillae
Sponsors & Collaborators
-
Fernanda de Paula Eduardo
lead OTHER
Principal Investigators
-
Fernanda de P Eduardo · Hospital Israelita Albert Einstein
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-29
- Primary Completion
- 2018-02-28
- Completion
- 2019-08-31
More Related Trials
-
EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY
NCT04657445 ·Status: COMPLETED
-
The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions
NCT05104424 ·Status: UNKNOWN ·Phase: PHASE1
-
Smell and Taste Disorders in COVID-19 Patients
NCT04427332 ·Status: COMPLETED
-
Effect of Photobiomodulation for Patients With Xerostomia
NCT05336981 ·Status: COMPLETED ·Phase: NA
-
Relationship Between MUC1 Expression and Gustatory Function in Postmenopausal Females
NCT04606524 ·Status: UNKNOWN
-
Retrospective Study on Anosmias and Ageusias Linked to Infection by Covid-19
NCT04681157 ·Status: UNKNOWN
-
Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia
NCT04388618 ·Status: COMPLETED
-
Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells
NCT00023491 ·Status: COMPLETED
-
Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients
NCT04361565 ·Status: COMPLETED
-
Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome
NCT02066896 ·Status: COMPLETED ·Phase: NA
-
Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines
NCT06929455 ·Status: RECRUITING ·Phase: NA
-
Effects of Photobiomodulation in Burning Mouth Syndrome
NCT04034849 ·Status: COMPLETED ·Phase: NA
-
Photobiomodulation in Salivary Production of Patients With Xerostomy
NCT03632096 ·Status: UNKNOWN ·Phase: PHASE2
-
Determination of the Safety and Effectiveness of an Oral Rinse in the Reduction of Medication Associated Metallic Taste
NCT02992314 ·Status: COMPLETED ·Phase: NA
-
Effect of Pilocarpine in Patients With Xerostomia
NCT02982577 ·Status: UNKNOWN ·Phase: PHASE4
-
A Description of Bacteria in the Mouths of Patients With Severe Aplastic Anemia
NCT01900119 ·Status: COMPLETED
-
Photobiomodulation on the Salivary Glands of Patients With Xerostomia Induced by the Use of Benzodiazepines
NCT05443022 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Salivary Flow Rate and Oral Function
NCT01020084 ·Status: COMPLETED
-
Effectiveness of Different Candies Against Bad Breath
NCT04589481 ·Status: COMPLETED ·Phase: NA
-
Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection
NCT04354857 ·Status: COMPLETED
-
Study Evaluating the Laser Diode Effect Burning Mouth Syndrome
NCT02757612 ·Status: COMPLETED ·Phase: NA
-
Interest of the Sialendoscopy Associated With a Local Injection of Corticosteroids in the Treatment of Radio-induced Xerostomia in Comparison With the Hygiene Rules
NCT04584164 ·Status: RECRUITING ·Phase: NA
-
Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome
NCT06040190 ·Status: RECRUITING ·Phase: PHASE4
-
Effect to the Photobiomodulation in the Burning Mouth Syndrome
NCT05871580 ·Status: COMPLETED ·Phase: NA
-
Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients
NCT06703372 ·Status: COMPLETED ·Phase: NA